These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

953 related items for PubMed ID: 26921743

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Lenzen MJ, Simsek C, de Boer SP, Van Mieghem NM, Regar E, de Jaegere PP, Akkerhuis KM, Ligthart JM, Zijlstra F, Serruys PW, Boersma E.
    EuroIntervention; 2016 Aug 20; 12(6):734-9. PubMed ID: 27542785
    [Abstract] [Full Text] [Related]

  • 24. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
    Dai J, Hou J, Xing L, Jia H, Hu S, Soeda T, Minami Y, Ong D, Vergallo R, Zhang S, Lee H, Yu B, Jang IK.
    Coron Artery Dis; 2017 May 20; 28(3):209-217. PubMed ID: 28059849
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    Räber L, Ueki Y, Otsuka T, Losdat S, Häner JD, Lonborg J, Fahrni G, Iglesias JF, van Geuns RJ, Ondracek AS, Radu Juul Jensen MD, Zanchin C, Stortecky S, Spirk D, Siontis GCM, Saleh L, Matter CM, Daemen J, Mach F, Heg D, Windecker S, Engstrøm T, Lang IM, Koskinas KC, PACMAN-AMI collaborators.
    JAMA; 2022 May 10; 327(18):1771-1781. PubMed ID: 35368058
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of statins on serial coronary calcification during atheroma progression and regression.
    Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nissen SE.
    J Am Coll Cardiol; 2015 Apr 07; 65(13):1273-1282. PubMed ID: 25835438
    [Abstract] [Full Text] [Related]

  • 30. Direct relationship of local C-reactive protein production and lipid pool characterized by integrated backscatter intravascular ultrasound: a preliminary observation.
    Kobayashi Y, Okura H, Kume T, Miyamoto Y, Yamada R, Kobayashi Y, Fukuhara K, Koyama T, Neishi Y, Yoshida K.
    Coron Artery Dis; 2015 Aug 07; 26(5):425-31. PubMed ID: 25886998
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.
    Eur Heart J; 2013 Nov 07; 34(41):3182-90. PubMed ID: 23886915
    [Abstract] [Full Text] [Related]

  • 33. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK, Lee CW, Kim YH, Park DW, Lee SW, Park CB, Jang JS, Han KH, Cheong SS, Kim JJ, Park SW, Park SJ.
    Am J Cardiol; 2006 Oct 01; 98(7):866-70. PubMed ID: 16996864
    [Abstract] [Full Text] [Related]

  • 34. Rationale of decreasing low-density lipoprotein cholesterol below 70 mg/dL in patients with coronary artery disease: A retrospective virtual histology-intravascular ultrasound study.
    Seo YH, Seo DJ, Song IG, Kim KH, Kwon TG, Bae JH.
    Cardiol J; 2018 Oct 01; 25(6):674-682. PubMed ID: 29341060
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
    Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Takeyama Y, Morino Y, Yamauchi T, Hibi K, Sozu T, Terashima M, Michishita I, TRUTH Investigators.
    J Atheroscler Thromb; 2013 Oct 01; 20(9):717-25. PubMed ID: 23748166
    [Abstract] [Full Text] [Related]

  • 37. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
    Her AY, Cho KI, Singh GB, An DS, Jeong YH, Koo BK, Shin ES.
    Int J Cardiovasc Imaging; 2017 Oct 01; 33(10):1445-1454. PubMed ID: 28555389
    [Abstract] [Full Text] [Related]

  • 38. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
    Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I, TRUTH Investigators.
    Am J Cardiol; 2012 May 01; 109(9):1247-53. PubMed ID: 22325089
    [Abstract] [Full Text] [Related]

  • 39. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
    Kovarnik T, Chen Z, Mintz GS, Wahle A, Bayerova K, Kral A, Chval M, Kopriva K, Lopez J, Sonka M, Linhart A.
    Cardiovasc Diabetol; 2017 Dec 07; 16(1):156. PubMed ID: 29212544
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.